Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma
Abstract It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) f...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202500131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850208073419849728 |
|---|---|
| author | Pengfei Chen Yue Liu Haiyan Huang Menglong Li Hui Xie Shubham Roy Jingsi Gu Jian Jin Kai Deng Lixin Du Bing Guo |
| author_facet | Pengfei Chen Yue Liu Haiyan Huang Menglong Li Hui Xie Shubham Roy Jingsi Gu Jian Jin Kai Deng Lixin Du Bing Guo |
| author_sort | Pengfei Chen |
| collection | DOAJ |
| description | Abstract It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) fluorescence imaging‐guided membrane‐targeted mild photothermal‐immunotherapy of glioblastoma using genetically engineered CSF1R/IL12‐macrophage membrane (MM)‐liposome hybrid nanovesicles, is reported. By mimicking lipophilic membrane probe (Dil) with octadecyl chains, a NIR‐II emissive photothermal dye (IRC18), which realizes labeling of nanovesicle lipid bilayers for biodistribution tracing, glioblastoma diagnosis, and molecular imaging of tumoral microenvironment, is synthesized. Importantly, MM and c‐RGD‐decorated liposome together offer BBB crossing, tumor targeting, and long‐term circulation; while, the genetically overexpressed CSF1R and IL12 on MM surface contribute to effective modulation of M2‐to‐M1 macrophage repolarization and local promotion of T cell cytotoxicity in glioblastoma microenvironment, respectively. Notably, through membrane fusion, IRC18 dyes translocate from nanovesicle lipid bilayers to glioblastoma membranes, which achieve membrane‐targeted mild photothermal therapy to ablate primary tumor and induce immunogenic cell death to promote antigen presentation. More importantly, the combined blockade of the CSF1‐CSF1R axis and IL‐12 enrichment not only reprograms the tumor microenvironment through macrophage M1 repolarization but also activates cytotoxic T cells, ultimately achieving complete glioblastoma eradication. This research provides an efficient theranostic paradigm for glioblastoma treatment. |
| format | Article |
| id | doaj-art-e83b65fc96f242118e7699581ae981bf |
| institution | OA Journals |
| issn | 2198-3844 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advanced Science |
| spelling | doaj-art-e83b65fc96f242118e7699581ae981bf2025-08-20T02:10:19ZengWileyAdvanced Science2198-38442025-06-011223n/an/a10.1002/advs.202500131Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of GlioblastomaPengfei Chen0Yue Liu1Haiyan Huang2Menglong Li3Hui Xie4Shubham Roy5Jingsi Gu6Jian Jin7Kai Deng8Lixin Du9Bing Guo10Department of Traumatic Orthopedics Shenzhen Longhua District Central Hospital Shenzhen 518110 ChinaSchool of Science Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application Harbin Institute of Technology Shenzhen 518055 ChinaSchool of Science Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application Harbin Institute of Technology Shenzhen 518055 ChinaSchool of Science Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application Harbin Institute of Technology Shenzhen 518055 ChinaChengdu Institute of Organic Chemistry Chinese Academy of Sciences Chengdu 610041 ChinaSchool of Science Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application Harbin Institute of Technology Shenzhen 518055 ChinaEducation Center and Experiments and Innovations Harbin Institute of Technology Shenzhen 518055 ChinaEducation Center and Experiments and Innovations Harbin Institute of Technology Shenzhen 518055 ChinaDepartment of Traumatic Orthopedics Shenzhen Longhua District Central Hospital Shenzhen 518110 ChinaDepartment of Medical Imaging Shenzhen Longhua District Key Laboratory of Neuroimaging Shenzhen Longhua District Central Hospital Shenzhen 518110 ChinaSchool of Science Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application Harbin Institute of Technology Shenzhen 518055 ChinaAbstract It is a big challenge for precision therapy of glioblastoma, mainly due to the existence of blood–brain barrier (BBB), tumor immunosuppressive microenvironment (TIM), and lack of efficient treatment paradigms. Herein, a theranostic nanoplatform for the second near‐infrared window (NIR‐II) fluorescence imaging‐guided membrane‐targeted mild photothermal‐immunotherapy of glioblastoma using genetically engineered CSF1R/IL12‐macrophage membrane (MM)‐liposome hybrid nanovesicles, is reported. By mimicking lipophilic membrane probe (Dil) with octadecyl chains, a NIR‐II emissive photothermal dye (IRC18), which realizes labeling of nanovesicle lipid bilayers for biodistribution tracing, glioblastoma diagnosis, and molecular imaging of tumoral microenvironment, is synthesized. Importantly, MM and c‐RGD‐decorated liposome together offer BBB crossing, tumor targeting, and long‐term circulation; while, the genetically overexpressed CSF1R and IL12 on MM surface contribute to effective modulation of M2‐to‐M1 macrophage repolarization and local promotion of T cell cytotoxicity in glioblastoma microenvironment, respectively. Notably, through membrane fusion, IRC18 dyes translocate from nanovesicle lipid bilayers to glioblastoma membranes, which achieve membrane‐targeted mild photothermal therapy to ablate primary tumor and induce immunogenic cell death to promote antigen presentation. More importantly, the combined blockade of the CSF1‐CSF1R axis and IL‐12 enrichment not only reprograms the tumor microenvironment through macrophage M1 repolarization but also activates cytotoxic T cells, ultimately achieving complete glioblastoma eradication. This research provides an efficient theranostic paradigm for glioblastoma treatment.https://doi.org/10.1002/advs.202500131biomimetic strategyglioblastomaimmunotherapyNIR‐II fluorescence imagingphotothermal therapy |
| spellingShingle | Pengfei Chen Yue Liu Haiyan Huang Menglong Li Hui Xie Shubham Roy Jingsi Gu Jian Jin Kai Deng Lixin Du Bing Guo Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma Advanced Science biomimetic strategy glioblastoma immunotherapy NIR‐II fluorescence imaging photothermal therapy |
| title | Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma |
| title_full | Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma |
| title_fullStr | Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma |
| title_full_unstemmed | Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma |
| title_short | Genetically Engineered IL12/CSF1R‐Macrophage Membrane‐Liposome Hybrid Nanovesicles for NIR‐II Fluorescence Imaging‐Guided and Membrane‐Targeted Mild Photothermal‐Immunotherapy of Glioblastoma |
| title_sort | genetically engineered il12 csf1r macrophage membrane liposome hybrid nanovesicles for nir ii fluorescence imaging guided and membrane targeted mild photothermal immunotherapy of glioblastoma |
| topic | biomimetic strategy glioblastoma immunotherapy NIR‐II fluorescence imaging photothermal therapy |
| url | https://doi.org/10.1002/advs.202500131 |
| work_keys_str_mv | AT pengfeichen geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT yueliu geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT haiyanhuang geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT menglongli geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT huixie geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT shubhamroy geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT jingsigu geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT jianjin geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT kaideng geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT lixindu geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma AT bingguo geneticallyengineeredil12csf1rmacrophagemembraneliposomehybridnanovesiclesforniriifluorescenceimagingguidedandmembranetargetedmildphotothermalimmunotherapyofglioblastoma |